BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23580588)

  • 1. Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
    Zellweger T; Stürm S; Rey S; Zlobec I; Gsponer JR; Rentsch CA; Terracciano LM; Bachmann A; Bubendorf L; Ruiz C
    Endocr Relat Cancer; 2013 Jun; 20(3):403-13. PubMed ID: 23580588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing roles of steroid nuclear receptors with prostate cancer progression.
    Savoy RM; Ghosh PM
    Endocr Relat Cancer; 2013 Aug; 20(4):C9-11. PubMed ID: 23744763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer.
    Gsponer JR; Braun M; Scheble VJ; Zellweger T; Bachmann A; Perner S; Vlajnic T; Srivastava M; Tan SH; Dobi A; Sesterhenn IA; Srivastava S; Bubendorf L; Ruiz C
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):126-31. PubMed ID: 24469092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.
    Lombardi APG; Cavalheiro RP; Porto CS; Vicente CM
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
    Cao F; Jin TY; Zhou YF
    Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
    Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ; Li G; Seth R; McArdle SE; Bishop MC; Rees RC
    Prostate; 2008 Feb; 68(2):210-22. PubMed ID: 18092350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of estrogen receptor alpha, estrogen receptor beta and androgen receptor in the pre-, peri- and post-pubertal stallion testis.
    Pearl CA; Mason H; Roser JF
    Anim Reprod Sci; 2011 May; 125(1-4):103-11. PubMed ID: 21497463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid hormone receptor expression in male breast cancer.
    Murphy CE; Carder PJ; Lansdown MR; Speirs V
    Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.
    Colciago A; Ruscica M; Mornati O; Piccolella M; Montagnani-Marelli M; Eberini I; Festuccia C; Magni P; Motta M; Negri-Cesi P
    Biomed Res Int; 2014; 2014():801473. PubMed ID: 24877132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
    Hess-Wilson JK; Webb SL; Daly HK; Leung YK; Boldison J; Comstock CE; Sartor MA; Ho SM; Knudsen KE
    Environ Health Perspect; 2007 Nov; 115(11):1646-53. PubMed ID: 18007998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.
    Leav I; Lau KM; Adams JY; McNeal JE; Taplin ME; Wang J; Singh H; Ho SM
    Am J Pathol; 2001 Jul; 159(1):79-92. PubMed ID: 11438457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population.
    Megas G; Chrisofos M; Anastasiou I; Tsitlidou A; Choreftaki T; Deliveliotis C
    Asian J Androl; 2015; 17(1):98-105. PubMed ID: 25219910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
    Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM
    PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
    Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
    Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane.
    Amaral C; Augusto TV; Almada M; Cunha SC; Correia-da-Silva G; Teixeira N
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165661. PubMed ID: 31891807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.
    Ylitalo EB; Thysell E; Landfors M; Brattsand M; Jernberg E; Crnalic S; Widmark A; Hultdin M; Bergh A; Degerman S; Wikström P
    Clin Epigenetics; 2021 Jun; 13(1):133. PubMed ID: 34193246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells.
    Pisolato R; Lombardi AP; Vicente CM; Lucas TF; Lazari MF; Porto CS
    Steroids; 2016 Mar; 107():74-86. PubMed ID: 26742628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.